Expert opinion survey of genomics research and development initiatives at Health Canada Online publication date: Fri, 19-Feb-2016
by Ivy Moffat; Carole L. Yauk; Julie Bourdon-Lacombe; Andrew Atkinson
International Journal of Biotechnology (IJBT), Vol. 14, No. 1, 2015
Abstract: Genomics is proposed to improve predictive toxicology and regulatory decision making. The Government of Canada established the Genomics R&D Initiative to build genomics capacity to support regulatory and operational mandates. However, the full impact is yet to be realised. We undertook an opinion analysis using targeted survey results from the Canadian Government health genomic research and risk assessment experts on key impacts, capacities, challenges, needs and foresight in the area of genomics. The experts reported: 1) identification of a substance's hazard and mode of action is currently the greatest impact of genomics on regulatory science; 2) national and international collaboration is essential to building capacity and leveraging resources; 3) collaborative case studies, exchange programs, international validation exercises and Health Canada's Genomics Working Group as key exercises to overcome existing challenges to the application of genomics. These opinions provide a basis for selecting projects funding areas to maximise genomics impacts on regulatory decision making.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Biotechnology (IJBT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com